Matthew Van Eman

Matthew Van Eman

McCarter & English, LLP

Contact
View Bio
RSS

Latest Posts › Intellectual Property Litigation

Share:

Senate Advances IP and Drug Pricing Legislation Amid Innovation Concerns

A Senate panel has advanced three sets of bipartisan bills purportedly aimed at reforming the intellectual property (IP) landscape and lowering the cost of prescription drugs. Together, these bills seek to address issues with...more

4/25/2025  /  Biosimilars , Drug Pricing , Federal Trade Commission (FTC) , Food and Drug Administration (FDA) , Generic Drugs , Intellectual Property Litigation , Patent Litigation , Pharmaceutical Industry , Pharmaceutical Patents , Proposed Legislation
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide